cPLA2 in Epilepsy: Shutting Down the Leaker at Its Source

Comment

Christina Gross. Epilepsy Curr. 2018 Sep-Oct.

. 2018 Sep-Oct;18(5):334-335.

doi: 10.5698/1535-7597.18.5.334.

No abstract available

Comment on

Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.
Rempe RG, Hartz AMS, Soldner ELB, Sokola BS, Alluri SR, Abner EL, Kryscio RJ, Pekcec A, Schlichtiger J, Bauer B. Rempe RG, et al. J Neurosci. 2018 May 2;38(18):4301-4315. doi: 10.1523/JNEUROSCI.2751-17.2018. Epub 2018 Apr 9. J Neurosci. 2018. PMID: 29632167 Free PMC article.

1. van Vliet EA, Aronica E, Gorter JA. Blood–brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol. 2015;38:26–34. - PubMed
1. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 2012;18:609–615. - PMC - PubMed
1. Sandhya TL, Ong WY, Horrocks LA, Farooqui AA. A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res. 1998;788:223–231. - PubMed
1. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11–21. - PubMed
1. Barbosa NR, Pittella F, Gattaz WF. Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. Phytomedicine. 2008;15:896–900. - PubMed